-
I166771-25mgPotent and high affinity BRD inhibitor: anti-inflammatory.
-
I166771-50mgPotent and high affinity BRD inhibitor: anti-inflammatory.
-
I166771-5mgPotent and high affinity BRD inhibitor: anti-inflammatory.
-
-
-
I287753-100mgI-BRD9 is developed from thienopyridone scaffold. It can also be used as an identifier for BRD9 regulated gene in Kasumi-1 cells involved in oncology and immune response pathways.
-
I287753-10mgI-BRD9 is developed from thienopyridone scaffold. It can also be used as an identifier for BRD9 regulated gene in Kasumi-1 cells involved in oncology and immune response pathways.
-
I287753-25mgI-BRD9 is developed from thienopyridone scaffold. It can also be used as an identifier for BRD9 regulated gene in Kasumi-1 cells involved in oncology and immune response pathways.
-
I287753-50mgI-BRD9 is developed from thienopyridone scaffold. It can also be used as an identifier for BRD9 regulated gene in Kasumi-1 cells involved in oncology and immune response pathways.
-
I287753-5mgI-BRD9 is developed from thienopyridone scaffold. It can also be used as an identifier for BRD9 regulated gene in Kasumi-1 cells involved in oncology and immune response pathways.
-
-